Stock Analysis
- Australia
- /
- Medical Equipment
- /
- ASX:NAN
ASX Growth Companies With High Insider Ownership In October 2024
Reviewed by Simply Wall St
As the ASX200 flirts with record highs, buoyed by strong performances in the Energy and Materials sectors, investor sentiment remains optimistic across the Australian market. In this environment of positive momentum, growth companies with high insider ownership stand out as potentially compelling opportunities, offering insights into management's confidence and alignment with shareholder interests.
Top 10 Growth Companies With High Insider Ownership In Australia
Name | Insider Ownership | Earnings Growth |
Clinuvel Pharmaceuticals (ASX:CUV) | 10.4% | 27.4% |
Genmin (ASX:GEN) | 12% | 117.7% |
Catalyst Metals (ASX:CYL) | 17% | 49.1% |
Hillgrove Resources (ASX:HGO) | 10.4% | 71.5% |
AVA Risk Group (ASX:AVA) | 15.7% | 118.8% |
Pointerra (ASX:3DP) | 20.1% | 126.4% |
Liontown Resources (ASX:LTR) | 14.7% | 61% |
Acrux (ASX:ACR) | 17.4% | 91.6% |
Adveritas (ASX:AV1) | 21.1% | 144.2% |
Plenti Group (ASX:PLT) | 12.8% | 106.4% |
Underneath we present a selection of stocks filtered out by our screen.
Mesoblast (ASX:MSB)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Mesoblast Limited develops regenerative medicine products across Australia, the United States, Singapore, and Switzerland, with a market cap of A$1.59 billion.
Operations: The company generates revenue of $5.90 million from the commercialization of its cell technology platform.
Insider Ownership: 22.2%
Mesoblast faces challenges as it was dropped from the S&P/ASX Emerging Companies Index and reported a net loss of US$87.96 million for FY2024. However, it shows potential with expected revenue growth of 45.8% annually, driven by the FDA's acceptance of its Biologics License Application resubmission for Ryoncil in treating SR-aGVHD. The recent A$72.7 million convertible note issuance supports future growth prospects despite past shareholder dilution and low insider trading activity.
- Click to explore a detailed breakdown of our findings in Mesoblast's earnings growth report.
- In light of our recent valuation report, it seems possible that Mesoblast is trading behind its estimated value.
Nanosonics (ASX:NAN)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Nanosonics Limited is a global infection prevention company with a market capitalization of A$1.11 billion.
Operations: The company's revenue primarily comes from its Healthcare Equipment segment, amounting to A$170.01 million.
Insider Ownership: 15.4%
Nanosonics, despite its recent drop from the S&P/ASX 200 Index, shows strong growth potential with forecasted earnings growth of 23.6% annually, outpacing the Australian market. However, its revenue growth is moderate at 8.7% per year and profit margins have decreased to 7.6%. Trading below fair value by 28.3%, it has seen more insider buying than selling recently but not in substantial volumes, indicating cautious optimism among insiders.
- Dive into the specifics of Nanosonics here with our thorough growth forecast report.
- Insights from our recent valuation report point to the potential overvaluation of Nanosonics shares in the market.
Pinnacle Investment Management Group (ASX:PNI)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Pinnacle Investment Management Group Limited is an investment management company based in Australia with a market capitalization of A$3.79 billion.
Operations: The company's revenue segment consists of Funds Management Operations amounting to A$48.99 million.
Insider Ownership: 31.5%
Pinnacle Investment Management Group is experiencing solid growth, with earnings expected to rise 14.4% annually, surpassing the Australian market's 12.2%. Revenue is forecasted to grow at 13.6% per year, outpacing the broader market's 5.5% growth rate. Recent financial results showed net income of A$90.35 million and sales of A$48.99 million for the year ended June 2024, reflecting steady progress despite no significant insider trading activity in recent months.
- Unlock comprehensive insights into our analysis of Pinnacle Investment Management Group stock in this growth report.
- Upon reviewing our latest valuation report, Pinnacle Investment Management Group's share price might be too optimistic.
Seize The Opportunity
- Gain an insight into the universe of 99 Fast Growing ASX Companies With High Insider Ownership by clicking here.
- Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
- Simply Wall St is your key to unlocking global market trends, a free user-friendly app for forward-thinking investors.
Searching for a Fresh Perspective?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Nanosonics might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About ASX:NAN
Nanosonics
Operates as an infection prevention company globally.